ATE235899T1 - Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität - Google Patents

Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität

Info

Publication number
ATE235899T1
ATE235899T1 AT99946255T AT99946255T ATE235899T1 AT E235899 T1 ATE235899 T1 AT E235899T1 AT 99946255 T AT99946255 T AT 99946255T AT 99946255 T AT99946255 T AT 99946255T AT E235899 T1 ATE235899 T1 AT E235899T1
Authority
AT
Austria
Prior art keywords
compounds
beta
therapeutic use
new therapeutic
agonistic activity
Prior art date
Application number
AT99946255T
Other languages
English (en)
Inventor
Charles Advenier
Luciano Manara
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE235899T1 publication Critical patent/ATE235899T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT99946255T 1998-10-14 1999-09-29 Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität ATE235899T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9812877A FR2784582B3 (fr) 1998-10-14 1998-10-14 Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste
PCT/FR1999/002308 WO2000021508A2 (fr) 1998-10-14 1999-09-29 Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste

Publications (1)

Publication Number Publication Date
ATE235899T1 true ATE235899T1 (de) 2003-04-15

Family

ID=9531553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99946255T ATE235899T1 (de) 1998-10-14 1999-09-29 Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität

Country Status (11)

Country Link
US (1) US6310050B1 (de)
EP (1) EP1121108B1 (de)
JP (1) JP2002527377A (de)
AT (1) ATE235899T1 (de)
AU (1) AU5868699A (de)
DE (1) DE69906558T2 (de)
DK (1) DK1121108T3 (de)
ES (1) ES2195612T3 (de)
FR (1) FR2784582B3 (de)
PT (1) PT1121108E (de)
WO (1) WO2000021508A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1258253A1 (de) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Neue heilmittel mit verwendung eines beta3-antagonisten
KR20050010512A (ko) * 2002-06-12 2005-01-27 스미또모 세이야꾸 가부시키가이샤 인돌, 인다졸 및 벤즈아졸류
EP2999461B1 (de) 2013-05-23 2020-03-11 The University of Newcastle Gezielte verabreichung von arzneimitteln in das myometrium
US20170065589A1 (en) 2014-05-06 2017-03-09 Anthony G. Visco Methods of treating or preventing preterm labor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65511B1 (en) * 1989-12-29 1995-11-01 Sanofi Sa New phenylethanolaminomethyltetralins
EP0627407A1 (de) 1993-05-28 1994-12-07 MIDY S.p.A. (7S)-7-(2R)-2(3-Chlorophenyl)-2-hydroxethylamino-5,6,7,8-Tetrahydronaphthalen-2-yloxy-Essigsäure, ihre pharmazeutisch akzeptablen Salze, mit Beta-3-adrenergischer agonistischer Aktivität und diese enthaltende pharmazeutische Zusammensetzung

Also Published As

Publication number Publication date
EP1121108A2 (de) 2001-08-08
WO2000021508A3 (fr) 2000-10-26
DE69906558D1 (de) 2003-05-08
DE69906558T2 (de) 2004-02-26
DK1121108T3 (da) 2003-07-21
ES2195612T3 (es) 2003-12-01
AU5868699A (en) 2000-05-01
EP1121108B1 (de) 2003-04-02
WO2000021508A2 (fr) 2000-04-20
US6310050B1 (en) 2001-10-30
JP2002527377A (ja) 2002-08-27
FR2784582B3 (fr) 2000-11-24
FR2784582A1 (fr) 2000-04-21
PT1121108E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
NZ517616A (en) Use of retigabin for treating neuropathic pain
ATE127474T1 (de) Neue peptidasen und isomerasen-inhibitoren.
ATE446097T1 (de) Verwendung von uridin in kombination mit cholin zur behandlung von gedächtnisstörungen
PL365637A1 (en) Quinazoline ditosylate salt compounds
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE60100625D1 (de) Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
NZ506771A (en) Modified factor viii
DE122009000036I1 (de) Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
EP1131107A4 (de) Antisense-modulation der expression von inhibitor-kappa-b-kinase-alpha
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
DE69906558D1 (de) Neue therapeutische anwendung von verbindungen mit beta-3-agonistischer aktivität
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
EP1056458A4 (de) Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
DE69930952D1 (de) Gesteuerte freisetzung von antidepressiva
DE60033569D1 (de) Neue verwendung von prodigiosin zur behandlung von diabetes mellitus
DE69824862D1 (de) Zusammenstellungen zur verbesserten wundheilung
ATE357206T1 (de) Zusammensetzungen enthaltend beta-galactosidase, n-acetyl-glucosaminidase und n-acetyl- galactosaminidase, die keine protease enthalten
EP1469867A4 (de) Verfahren zur behandlung von halitose
ATE272651T1 (de) Verbindungen mit wachstumshormon-freisetzender eigenschaft
FR2816633B1 (fr) Methode de criblage d'agents susceptibles de traiter l'obesite
BR9908392A (pt) Uso de antagonistas de d1/d5 para o tratamento de distúrbios obsessivos compulsivos, distúrbios somatofórmicos, distúrbios dissociativos, distúrbios de alimentação, distúrbios de controle de impulsos e autismo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1121108

Country of ref document: EP